Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
A 'The Office' spinoff, 'The Paper,' follows a struggling Ohio newspaper with an optimistic new editor-in-chief and an unconventional newsroom staff.
Trump administration appeals court order restricting immigration raids in California, raising concerns over enforcement and constitutional protections.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
A 'The Office' spinoff, 'The Paper,' follows a struggling Ohio newspaper with an optimistic new editor-in-chief and an unconventional newsroom staff.
Trump administration appeals court order restricting immigration raids in California, raising concerns over enforcement and constitutional protections.